Dana Farber Cancer Institute SC-7

Boston, Massachusetts 02215

0 studies enrolling now · 3 studies all time

What they study most

BRAF Mutant Colorectal Cancer, Cervical Squamous Cell Cancer, Esophageal Squamous Cell Cancer, Head and Neck Squamous Cell Cancer, Lung Squamous Cell Cancer, Malignant Rhabdoid Tumors (MRT), Medulloblastoma, Melanoma, Neuroblastoma, Pancreatic Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands — Completed
• Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma — Stopped early
• A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) — Completed